Veterinary Medicines

Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water

Authorised
  • Lincomycin hydrochloride
  • Spectinomycin sulfate
Download as PDF

Product identification

Medicine name:
Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water
LINCO-SPECTIN 100, 222/444,7 MG/G POUDRE POUR ADMINISTRATION DANS L'EAU DE BOISSON POUR PORCINS ET POULETS
Active substance:
  • Lincomycin hydrochloride
  • Spectinomycin sulfate
Target species:
  • Poultry
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    241.90
    milligram(s)
    /
    1.00
    gram(s)
  • Spectinomycin sulfate
    575.90
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Poultry
      • Meat and offal
        5
        day
      • Eggs
        no withdrawal period
    • Pig
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Linco-Spectin 100 222 mg/g - 444.7 mg/g pwdr. for drinking water 1.5 kg
  • Linco-Spectin 100 222 mg/g - 444.7 mg/g pwdr. for drinking water 150 g

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/8295078 3/1992
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0029/001
Concerned member states:
  • Austria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."